Hospital Costs Completed Phase 3 Trials for Capecitabine (DB01101)

IndicationStatusPhase
DBCOND0046479 (Hospital Costs)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01080547Study Comparing Conventional and Fast Track Multi-Discipline Treatment Interventions for Colorectal CancerTreatment